Overview
TFX market data
Price History
TFX price chart · 1M
- O
- 125.61
- H
- 125.61
- L
- 122.87
- C
- 123.72
- Vol
- 9,521.00
Daily history from Jan 4, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $125.61
- Previous Close
- $124.70
- Day High
- $125.61
- Day Low
- $122.87
- 52 Week High
- $143.98
- 52 Week Low
- $99.43
- 7 Day Return
- -1.00%
- 30 Day Return
- -9.69%
- 90 Day Return
- -7.55%
- 1 Year Return
- -1.52%
- Daily Notional Volume
- $1.2M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$20.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.85 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -39.7% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $100.18 – $145.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5.4B · P/B 1.73 · P/S 2.06.
Company News
10 captured
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for NowZacks Investment Research ·
Is This the Right Time to Add DGX Stock to Your Portfolio?Zacks Investment Research ·
Reasons to Retain Penumbra Stock in Your Portfolio for NowZacks Investment Research ·
Is This the Right Time to Retain Resmed Stock in Your Portfolio?Zacks Investment Research ·